FDA Permits Marketing of New Tissue Expander for Women Undergoing Breast Reconstruction Following Mastectomy

News The U.S. Food and Drug Administration today allowed marketing of a new tissue expander system for soft tissue expansion in two-stage breast reconstruction following mastectomy. Contributed Author: The U.S. Food and Drug Administration Topics: Implantables